Spasticity Clinical Trial
Official title:
Prevalence of Spasticity in Adults With Mental Retardation Residing in a Community Setting
This survey aims to investigate the prevalence of spasticity among adults who live in community settings in Davidson County, Tennessee. The treatment of spasticity in those who live in community homes could significantly increase a person's quality of life by allowing them to participate more independently in activities of daily living, or by making assistance easier for caregivers.
The process of deinstitutionalization has transitioned a large majority of persons with
developmental disabilities into the community over the past several decades, and that number
will only increase going forward. There are 926 people in this region who are provided
assistance through the Division of Mental Retardation Services (DMRS). People with
developmental disabilities frequently have comorbidities such as spasticity that hinder
their ability to participate in activities of daily living. Spasticity results from brain or
spinal cord injury and can produce increased muscle tone, causing joint stiffness,
contractures and pain that can interfere with recommended treatment. A previous survey
conducted at Clover Bottom Developmental Center investigated care areas typically affected
by spasticity, including splinting, hygiene, dressing, transfers, positioning, ambulation,
and engaging in other functional activities. Pfister et al. reported the prevalence of
spasticity in the developmental center to be 35% (72/205); of those people, the Survey
Physician felt that 75% (54/72) would achieve a functional benefit from treatment.
Primary endpoints will assess the prevalence of spasticity in adults who reside in the
community, and whether or not spasticity impacts activities of daily living. When
appropriate, potential care area goals will be identified, and treatment options will be
recorded. Secondary endpoints will examine whether or not participants currently receive
treatment for spasticity; if so, what treatment is being used; and which care areas are most
impacted by spasticity.
;
Observational Model: Ecologic or Community, Time Perspective: Cross-Sectional
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06150729 -
Study of Intramuscular Injections of OnabotulinumtoxinA to Assess Change in Disease Activity in Pediatric Participants With Spasticity Associated With Cerebral Palsy
|
||
| Completed |
NCT02400619 -
Shockwaves Therapy and Botulinum Toxin for the Treatment of Spasticity in Patients With Cerebral Palsy. A Cross Over RCT
|
Phase 1 | |
| Completed |
NCT01945684 -
A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity
|
Phase 3 | |
| Completed |
NCT02261142 -
Efficacy and Cost-effectiveness of Spasticity Treatment With Multifocal TENS
|
N/A | |
| Completed |
NCT01444794 -
Adult Subjects Suffering From Lower Limb Spasticity Following Stroke
|
||
| Terminated |
NCT02877836 -
Functional MRI and DTI in the Preoperative Assessment of Dystonia
|
N/A | |
| Completed |
NCT02334683 -
Compare Two Guidance Techniques for Botulinum Toxin Injections for the Treatment of Limb Spasticity and Focal Dystonia
|
N/A | |
| Completed |
NCT02170779 -
Developing and Testing a Comprehensive MS Spasticity Management Program
|
Phase 2 | |
| Recruiting |
NCT05674604 -
Cryoneurolysis for Knee and Shoulder Pain in an Inpatient Setting
|
||
| Not yet recruiting |
NCT05926596 -
Leg Stretching Using an Exoskeleton on Demand for People With Spasticity
|
N/A | |
| Terminated |
NCT01712087 -
Long-term Surveillance of the MedStream Programmable Infusion System
|
||
| Completed |
NCT03906305 -
Dry Needling and Bobath Treatment Clinical Effects Focused on Stroke Patients
|
N/A | |
| Completed |
NCT03302741 -
Imaging of 3D Innervation Zone Distribution in Spastic Muscles From High-density Surface EMG Recordings
|
Phase 4 | |
| Completed |
NCT02291159 -
Effects of DNHS Technique in the Treatment of Upper Limb Spasticity and Function in Stroke
|
N/A | |
| Completed |
NCT01743651 -
Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
|
Phase 3 | |
| Completed |
NCT01523210 -
DTI Study of the Influence of Physiotherapy on Distribution of BoNT in Spastic Muscle
|
N/A | |
| Completed |
NCT02073513 -
Kinesiotaping the Hand in Cerebral Palsy
|
N/A | |
| Completed |
NCT00607542 -
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
|
Phase 1/Phase 2 | |
| Completed |
NCT00702468 -
Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis
|
Phase 3 | |
| Active, not recruiting |
NCT04815967 -
Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity
|
Phase 2/Phase 3 |